Recognition underscores company’s commitment to transparency and values
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been ranked in the top 10 for overall transparency and awarded Best Code of Conduct among S&P 250 companies in the fifth annual U.S. Transparency Awards by Labrador, a global communications firm specializing in corporate disclosures.
“Particularly now, when stakeholders are evaluating the moral and ethical behaviors of companies, the code of conduct is the roadmap that provides insight into a company’s values — it guides and influences the behavior of its Board and employees,” said Broc Romanek, industry-renowned expert and chair of the independent Transparency Scientific Committee, which will oversee the awards starting next year. “Among the many ways BD stood out among its peers, it provides a user-friendly interface, offers direct links to policies to ensure accessibility and includes an easy-to-understand graphic about the reporting process so that there can be no confusion.”
Michelle Quinn, executive vice president and general counsel for BD said, “Transparency is a vital part of BD’s strategy and being recognized for our transparency along with Best Code of Conduct in the U.S. Transparency Awards further demonstrates our commitment to doing what is right and continuing to build trust with our customers and their patients, investors, partners – and each other.”
Each year, experts from Labrador evaluate the proxy statements, Form 10-Ks, investor relations websites, codes of conduct, and for the first time, ESG reports from the S&P 250. The team collected more than 59,250 data points and reviewed each organization’s disclosure documents using 237 objective criteria that reflect the award’s five pillars of transparency: clarity, accessibility, precision, comparability and availability. The Labrador experts reviewed 29 criteria specific to the code of conduct to determine the 2023 rankings.
